| Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ... Nature medicine 22 (10), 1094-1100, 2016 | 280 | 2016 |
| A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ... Nature 560 (7720), 644-648, 2018 | 243 | 2018 |
| Host blood RNA signatures predict the outcome of tuberculosis treatment EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ... Tuberculosis 107, 48-58, 2017 | 170 | 2017 |
| Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and … NN Chegou, JS Sutherland, S Malherbe, AC Crampin, PLAM Corstjens, ... Thorax 71 (9), 785-794, 2016 | 167 | 2016 |
| RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ... Scientific reports 10 (1), 8629, 2020 | 110 | 2020 |
| Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ... The Lancet Infectious Diseases 21 (3), 354-365, 2021 | 106 | 2021 |
| Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: the TANDEM study C Ugarte-Gil, B Alisjahbana, K Ronacher, AL Riza, RC Koesoemadinata, ... Clinical Infectious Diseases 70 (5), 780-788, 2020 | 106 | 2020 |
| Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response R Jacobs, S Malherbe, AG Loxton, K Stanley, G Van Der Spuy, G Walzl, ... Oncotarget 7 (36), 57581, 2016 | 100 | 2016 |
| Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment R Jacobs, E Tshehla, S Malherbe, M Kriel, AG Loxton, K Stanley, ... Cytokine 81, 50-56, 2016 | 75 | 2016 |
| Diagnostic potential of novel salivary host biomarkers as candidates for the immunological diagnosis of tuberculosis disease and monitoring of tuberculosis treatment response R Jacobs, E Maasdorp, S Malherbe, AG Loxton, K Stanley, ... PloS one 11 (8), e0160546, 2016 | 59 | 2016 |
| Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa JA Shaw, M Meiring, T Cummins, NN Chegou, C Claassen, N Du Plessis, ... Plos one 16 (2), e0247852, 2021 | 58 | 2021 |
| Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results JS Sutherland, G van der Spuy, A Gindeh, NTT Thuong, AR Namuganga, ... Clinical Infectious Diseases 74 (12), 2136-2141, 2022 | 57 | 2022 |
| Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis NN Chegou, JS Sutherland, AR Namuganga, PLAM Corstjens, A Geluk, ... Scientific reports 8 (1), 2675, 2018 | 54 | 2018 |
| Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa H Strijdom, P De Boever, G Walzl, MF Essop, TS Nawrot, I Webster, ... BMC infectious diseases 17, 1-9, 2017 | 44 | 2017 |
| Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study SC Mendelsohn, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, ... The Lancet Global Health 9 (6), e841-e853, 2021 | 42 | 2021 |
| The functional response of B cells to antigenic stimulation: a preliminary report of latent tuberculosis WJ Du Plessis, L Kleynhans, N Du Plessis, K Stanley, ST Malherbe, ... PloS one 11 (4), e0152710, 2016 | 39 | 2016 |
| Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease DO Awoniyi, A Teuchert, JS Sutherland, H Mayanja-Kizza, R Howe, ... Journal of Infection 73 (3), 219-230, 2016 | 37 | 2016 |
| Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis C Eckold, V Kumar, J Weiner, B Alisjahbana, AL Riza, K Ronacher, ... Clinical Infectious Diseases 72 (1), 69-78, 2021 | 34 | 2021 |
| Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa D Grint, B Alisjhabana, C Ugarte-Gil, AL Riza, G Walzl, F Pearson, ... Bulletin of the World Health Organization 96 (11), 738, 2018 | 33 | 2018 |
| Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response ST Malherbe, RY Chen, P Dupont, I Kant, M Kriel, AG Loxton, B Smith, ... EJNMMI research 10, 1-15, 2020 | 31 | 2020 |
